Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

European Research Council grants worth more than €16.3 million have today been awarded to eight University of Oxford researchers for a range of cutting-edge projects.

Oxford skyline

The highly-competitive awards, given to Europe’s most innovative, high-impact academics, have been won by researchers from across the university’s four divisions - representing the highest number of consolidator grants awarded in the UK. These coveted prizes are awarded by the ERC to researchers with between seven and 12 years’ post-doctoral experience, ‘all selected solely based on excellence’, according to Mariya Gabriel, European Commissioner for Innovation, Research, Culture, Education and Youth.

Professor Patrick Grant, Pro-Vice-Chancellor for Research at the University of Oxford said: ‘These ERC awards are a strong endorsement of the quality and adventure of the research proposed by early and mid-career researchers across the University, in diverse subjects including demography, history, zoology, biology and chemistry.’

Oxford’s winners, each awarded research funding of some €2 million, include Dr Alfredo Castello in the Department of Biochemistry. A specialist in researching the role of RNA-binding proteins in virus infection, Dr Castello’s work has uncovered dozens of RBPs, which are crucial for viruses. Millions of people die each year from RNA viruses.  It is critical to understand the interactions that viruses establish with the host cell.

The full story is available on the University of Oxford website

Similar stories

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

Medical Sciences Division receives REF 2021 results

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021. REF is the UK-wide assessment of research in universities, and provides an expert evaluation of the quality of the research outputs, impact and environment at subject level in each university.